Bicarbonate

Bicarbonate

SCHEMBL2286533

CCOc1ccc(C)cc1.O=C(O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.60
MAOB P27338 1/20 0.58
PARP10 Q53GL7 1/20 0.57
PLA2G4B P0C869 1/20 0.55
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
POLB P06746 3/20 0.54
ALDH1A1 P00352 1/20 0.54
MAPT P10636 1/20 0.54
HTT P42858 1/20 0.54
RECQL P46063 1/20 0.54
NPC1 O15118 1/20 0.53
PLK1 P53350 1/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
LTA4H P09960 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL92159 0.89 NQO1 (0.78) NQO1MAOBPARP10MEN1KMT2A
Ammonia Solution, Strong SCHEMBL27799297 0.86 NQO1 (0.74) NQO1MAOBPARP10MEN1KMT2A
SCHEMBL30776959 0.86 KMT2A (0.69) NQO1L3MBTL1MAOBPARP10PLA2G4B
SCHEMBL28418500 0.86 MAOB (0.62) NQO1MAOBPARP10PLA2G4BKMT2A
SCHEMBL7631521 0.83 NPC1 (0.64) L3MBTL1MAOBPARP10MEN1KMT2A
Cyanide SCHEMBL28150915 0.82 NQO1 (0.67) NQO1MAOBPARP10MEN1KMT2A
SCHEMBL2492122 0.82 NQO1 (0.67) NQO1MAOBALDH1A1MAPTNPC1
SCHEMBL12736285 0.82 NQO1 (0.67) NQO1MAOBALDH1A1MAPTNPC1
SCHEMBL8737704 0.82 LTA4H (0.68) NQO1MAOBPARP10MEN1KMT2A
SCHEMBL12536665 0.81 KMT2A (0.66) MAOBPARP10MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110206568-A1 PROCESS FOR THE PREPARATION OF DIARYL CARBONATES OR ARYLALKYL CARBONATES FROM DIALKYL CARBONATES BAYER MATERIALSCIENCE AG (DE) 2011-08-25 US disclosed
US-8003817-B2 Process for the preparation of diaryl carbonates or arylalkyl carbonates from dialkyl carbonates BAYER MATERIALSCIENCE AG (DE) 2011-08-23 US disclosed
US-20080293960-A1 Process For The Preparation Of Diaryl Carbonates Or Arylalkyl Carbonates From Dialkyl Carbonates BAYER MATERIALSCIENCE AG (DE) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293960-A1 Process For The Preparation Of Diaryl Carbonates Or Arylalkyl Carbonates From Dialkyl Carbonates HDHD5, ALKBH3, AHR NQO1 2341/4885L3MBTL1 4844/4885MAOB 2363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.